What is CZECRIN?
CZECRIN is a large research infrastructure, established by a decision of the Ministry of Education, Youth and Sports (MEYS), which is also financed from the earmarked support of large research infrastructures. The decision to establish the research infrastructure was signed on 21 March 2014, on the basis of cooperation between Masaryk University (MU; host institution) and the University Hospital of St. Anny v Brně (FNUSA; partner institution) with the aim of creating a nationwide scientific network of partners for conducting non-commercial clinical research and clinical studies at the national and international level. For the years 2020 – 2022, a financial subsidy from the Ministry of Education, Youth and Sports (LM2018128) was provided for the solution of a large research infrastructure project. Similarly to other clinical research infrastructures within ECRIN-ERIC, LRI CZECRIN does not have a legal entity’s status. Masaryk University (MU) as one of the leading Central European scientific institutions is the legal entity and the host institution of CZECRIN. Research infrastructures operated by MU are an important pillar of research and innovation systems in the Czech Republic. Their importance is emphasized by participation in 16 research infrastructures listed in the Czech National Roadmap for Large RDI Infrastructures. Nine of these projects are also part of research infrastructures of pan-European interest included in the European Strategy Forum for Research Infrastructures (ESFRI). Eight research infrastructures are in the field of health and nutrition.
FNUSA – the founding member – is a university hospital with excellent clinical research capacities concentrated in the International Center for Clinical Studies (ICRC). Its support in the coordination of clinical workplaces’ networks, technical and administrative support is an essential part of CZECRIN.
At present, large research infrastructure CZECRIN is a nationwide and fully-functional research infrastructure supporting and implementing academic clinical research in the Czech Republic. LRI CZECRIN provides unique expertise, research, development, manufacturing and implementation capacities in the medical sciences. CZECRIN supports national and international cooperation in clinical research for the benefit of patients, citizens and healthcare. All this includes CZECRIN’s new comprehensive strategy with a vision characterized by the motto: “… towards patient-oriented medicine.”
Most likely, each of us has encountered a health condition in our daily lives in which he was forced to take a medicine. It could be a short-term drug administration for sore throat, cold or flu, other times. It is necessary to take the drug for a long time. The truth is that the route of a drug or the life cycle of a drug is not a matter of a few days. It is a process of many years of research, laboratory testing and clinical trials. For such a drug development and reaching the patient…